Rainbow Children's Medicare Ltd Q4 FY25 Results
RAINBOWQ4 FY25 ResultsAnnounced 24 May 2025, 06:49 pm| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 370.11 | 7.0% |
| Total Income | 384.63 | 6.5% |
| Expenditure | 307.67 | 3.0% |
| PBT | 76.97 | 18.4% |
| Net Profit | 56.55 | 18.0% |
| OPM | 31.00% | 24.03pp |
| NPM | 14.70% | 2.06pp |
| EPS | 5.55 | 17.9% |
Rainbow Children’s Medicare Limited Reports 8.5% Revenue Growth in Q4 FY25
24 May 2025 · 24 May 2025, 07:11 pm
Summary
Rainbow Children’s Medicare Limited, India’s leading pediatric multi-specialty and perinatal care hospital chain, has announced its financial results for the fourth quarter and the financial year FY24-25, ended March 31, 2025. The company reported an 8.5% growth in revenue and a 10.7% growth in PAT compared to the same period last year.
Key Highlights
- 1
RCML reported an 8.5% growth in revenue in Q4 FY25 compared to Q4 FY24
- 2
EBITDA increased by 8.7% in Q4 FY25 compared to Q4 FY24
- 3
PAT grew by 10.7% in Q4 FY25 compared to Q4 FY24
- 4
Rainbow performed its first liver transplant at the hub hospital in Chennai and secured the liver transplant license for the Bengaluru hub
- 5
Rainbow’s fertility services at its Kondapur hospital in Hyderabad have received re-accreditation from the Joint Commission International (JCI)
- 6
Rainbow’s ongoing network expansion remains firmly on track
- 7
The company invested Rs. 437 Mn in capital expenditures towards expanding and enhancing their services at existing hospitals in Q4 FY25
Management Comments
Shreya poe ssies Mitra /tesetesos30 Shreya Mitra
On the operational front, performance for the quarter was modest compared to the second and third quarters of the year. However, all new beds commissioned over the past year have been seamlessly integrated into the Rainbow network. Notably, the company performed its first liver transplant at the hub hospital in Chennai and secured the liver transplant license for the Bengaluru hub. These achievements highlight Rainbow’s focused efforts to enhance its tertiary and quaternary care capabilities in Bengaluru and Chennai, with the aim of evolving these hubs to the same level of excellence as established in Hyderabad.
Informational and educational content only. Not investment advice.